Thwarting Prostate Cancer (IMAGE)
Caption
Graph shows elevated activity of a transcription-factor network that includes the molecule Onecut2 in tumors of patients whose prostate cancer resisted hormone therapy (above purple bar) compared with other types. (Michael Freeman, Ph.D.)
Credit
Nature Publishing Group (Nature Research)
Usage Restrictions
None
License
Licensed content